The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cabozantinib (CABO) tolerance and efficacy for patients with advanced hepatocellular carcinoma (HCC) after failure of sorafenib (SOR) in a French population: CLERANCE, a phase 4 trial.
 
Philippe Merle
Honoraria - AstraZeneca; Bayer Schering Pharma; Bristol-Myers Squibb; Eisai; Ipsen; Lilly; Merck; Roche
Consulting or Advisory Role - Bayer Schering Pharma
 
Mohamed Bouattour
Honoraria - Bayer Schering Pharma
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Roche; SERVIER; Sirtex Medical; Taiho Pharmaceutical
Speakers' Bureau - Bayer; Roche; SIRTEX Medical
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Ipsen; Roche
 
Jean-Frédéric Blanc
Honoraria - AstraZeneca; Bayer Schering Pharma; Eisai; INCYTE; IPSEN; Roche; SERVIER
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; IPSEN; ROCHE; SERVIER
Travel, Accommodations, Expenses - Bayer Schering Pharma
 
Jean-Marie Peron
Honoraria - Bayer; Ipsen; Roche
Consulting or Advisory Role - Bayer; Ipsen; Roche
Speakers' Bureau - Bayer; Ipsen; Roche
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Marilyne Debette-Gratien
No Relationships to Disclose
 
Pierre Nahon
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Roche
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Roche
Research Funding - AstraZeneca; Bristol-Myers Squibb; Eisai
Travel, Accommodations, Expenses - AstraZeneca; Bayer; Bristol-Myers Squibb; Eisai; Ipsen; Roche
 
Eric Nguyen-Khac
No Relationships to Disclose
 
Jean Marc Phelip
No Relationships to Disclose
 
Eric Assenat
No Relationships to Disclose
 
Vincent Bourgeois
No Relationships to Disclose
 
Carine Richou
No Relationships to Disclose
 
Alexandra Heurgue
Honoraria - AstraZeneca; Bayer; Gilead Sciences; Ipsen; MSD; MSD
Consulting or Advisory Role - Intercept Pharmaceuticals; Ipsen
 
Jean-Pierre Bronowicki
No Relationships to Disclose
 
Isabelle Ollivier-Hourmand
Speakers' Bureau - Gilead Sciences
Travel, Accommodations, Expenses - Abbvie; Bayer; Gilead Sciences; Roche Pharma AG
 
Thomas Uguen
No Relationships to Disclose
 
Stéphane Cattan
No Relationships to Disclose
 
Sylvie Thevenon
No Relationships to Disclose
 
Camille Boucheny
No Relationships to Disclose
 
Pierre Pradat
No Relationships to Disclose